Fermenta Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and approve unaudited financial results ....
FERMENTA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fermenta Biotech has informed BSE that its Board of Directors will meet on Monday, February 9, 2026. The agenda includes considering and approving the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The trading window for the company's securities has been closed from January 1, 2026 and will remain so until 48 hours after the results are declared. The filing is made under Regulation 29 of SEBI's Listing Obligations and Disclosure Requirements, 2015.
This is a routine regulatory filing ahead of the Q3 FY26 earnings announcement. Shareholders should watch for the results on or shortly after February 9, 2026; the document itself has no direct impact on stock price or fundamentals.